Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
results symbols : Lly save search
Lilly Confirms Date and Conference Call for First-Quarter 2024 Financial Results Announcement
Published: 2024-04-16 (Crawled : 15:00) - biospace.com/
LLY | News | $733.3 -1.66% 1.4M
|
Health Technology
|
| O: 0.09%
H: 0.0%
C: 0.0%
announcement conference for financial results
Zura Bio Reports Full Year 2023 Financial Results, Business Highlights, and Appoints Robert Lisicki as Chief Executive Officer
Published: 2024-03-28 (Crawled : 12:00) - biospace.com/
LLY | News | $733.3 -1.66% 1.4M
|
Health Technology
|
| O: 0.28%
H: 1.71%
C: -0.3%
business year financial
Erasca Reports Fourth Quarter 2023 and Full Year 2023 Business Updates and Financial Results
Published: 2024-03-27 (Crawled : 20:00) - globenewswire.com
NVSEF | News | $96.0 52K
|
Health Technology
|
| O: -100.0%
H: NaN%
C: Infinity%
ERAS | $1.87 -3.11% 470K
|
|
| O: 17.48%
H: 6.94%
C: -14.88%
NVS | News | $98.31 1.06% 1.6M
|
Health Technology
|
| O: 0.52%
H: 0.0%
C: 0.0%
LLY | News | $733.3 -1.66% 1.4M
|
Health Technology
|
| O: 0.28%
H: 1.71%
C: -0.3%
business year financial results
Precision BioSciences Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Provides Business Update
Published: 2024-03-27 (Crawled : 11:00) - biospace.com/
CRBU | $3.83 -3.77% 570K
|
Health Technology
|
| O: 1.58%
H: 0.58%
C: -0.39%
NVS | News | $98.31 1.06% 1.6M
|
Health Technology
|
| O: 0.24%
H: 0.42%
C: 0.4%
LLY | News | $733.3 -1.66% 1.4M
|
Health Technology
|
| O: 0.49%
H: 0.84%
C: -0.07%
TGTX | $13.92 -2.32% 2.1M
|
Health Technology
|
| O: 0.71%
H: 0.39%
C: 0.13%
DTIL | $9.995 -2.3% 24K
|
Health Technology
|
| O: 0.39%
H: 4.22%
C: 1.41%
precision business year update financial results
ProQR Announces Year End 2023 Operating and Financial Results
Published: 2024-03-13 (Crawled : 11:00) - globenewswire.com
LLY | News | $733.3 -1.66% 1.4M
|
Health Technology
|
| O: 0.27%
H: 0.5%
C: 0.11%
PRQR | News | $2.0 -0.99% 33K
|
Health Technology
|
| O: -1.46%
H: 21.78%
C: 15.35%
year financial results
Merus Announces Financial Results for the Fourth Quarter and Full Year 2023 and Provides Business Update
Published: 2024-02-28 (Crawled : 21:00) - globenewswire.com
LLY | News | $733.3 -1.66% 1.4M
|
Health Technology
|
| O: -0.6%
H: 0.45%
C: 0.08%
MRUS | $41.59 1.89% 610K
|
Health Technology
|
| O: 2.3%
H: 0.58%
C: -2.69%
INCY | $51.45 -0.39% 720K
|
Health Technology
|
| O: 0.38%
H: 0.0%
C: -3.07%
business year update financial results
Verve Therapeutics Provides Pipeline Progress and Reports Fourth Quarter and Full Year 2023 Financial Results
Published: 2024-02-27 (Crawled : 12:30) - globenewswire.com
VERV | $6.62 -3.78% 490K
|
Professional, Scientific, and T...
|
| O: 5.89%
H: 15.96%
C: 14.72%
LLY | News | $733.3 -1.66% 1.4M
|
Health Technology
|
| O: -2.2%
H: 2.39%
C: 1.34%
VRTX | $401.58 -0.82% 430K
|
Health Technology
|
| O: 0.15%
H: 0.66%
C: -0.74%
year pipeline therapeutics financial results
Aclaris Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Corporate Update
Published: 2024-02-27 (Crawled : 12:00) - globenewswire.com
LLY | News | $733.3 -1.66% 1.4M
|
Health Technology
|
| O: -2.2%
H: 2.39%
C: 1.34%
ACRS | $1.175 -3.69% 890K
|
Health Technology
|
| O: 2.48%
H: 10.48%
C: -3.23%
year update therapeutics financial results
United Therapeutics Corporation Reports Fourth Quarter and Full Year 2023 Financial Results
Published: 2024-02-21 (Crawled : 12:00) - biospace.com/
LLY | News | $733.3 -1.66% 1.4M
|
Health Technology
|
| O: -2.33%
H: 1.55%
C: 1.06%
UTHR | $239.7 2.23% 330K
|
Health Technology
|
| O: 2.59%
H: 3.66%
C: -0.24%
year corporation therapeutics financial results
Lilly Confirms Date and Conference Call for Fourth-Quarter 2023 Financial Results and 2024 Financial Guidance
Published: 2024-01-23 (Crawled : 15:00) - prnewswire.com
LLY | News | $733.3 -1.66% 1.4M
|
Health Technology
|
| O: -0.51%
H: 0.37%
C: 0.32%
conference financial results
Lantheus and POINT Biopharma Announce Positive Topline Results from Pivotal SPLASH Trial in Metastatic Castration-Resistant Prostate Cancer
Published: 2023-12-18 (Crawled : 12:30) - globenewswire.com
PNT | $13.68 2.63% 0.15% 0
|
|
| O: -10.09%
H: 0.0%
C: 0.0%
LLY | News | $733.3 -1.66% 1.4M
|
Health Technology
|
| O: 1.61%
H: 1.14%
C: 0.57%
LNTH | $64.71 0.47% 290K
|
Health Technology
|
| O: -19.87%
H: 5.04%
C: -8.75%
positive cancer biopharma topline trial results
Innovent Announces Publication of Mazdutide (IBI362) Phase 2 Full Results in Chinese Patients with Overweight or Obesity in Nature Communications
Published: 2023-12-18 (Crawled : 00:00) - prnewswire.com
LLY | News | $733.3 -1.66% 1.4M
|
Health Technology
|
| O: 1.61%
H: 1.14%
C: 0.57%
SNY | News | $46.765 -1.94% 1.2M
|
Health Technology
|
| O: 1.25%
H: 0.0%
C: 0.0%
INCY | $51.45 -0.39% 720K
|
Health Technology
|
| O: -0.03%
H: 0.06%
C: -2.67%
ibi362 obesity publication communications chinese results
Sermonix Pharmaceuticals Shares Results of Third Survey on ESR1 and Metastatic Breast Cancer Patient Quality of Life
Published: 2023-12-12 (Crawled : 22:00) - biospace.com/
LLY | News | $733.3 -1.66% 1.4M
|
Health Technology
|
| O: -2.88%
H: 0.0%
C: 0.0%
LGND | $70.74 1.22% 63K
|
Health Technology
|
| O: 0.21%
H: 1.18%
C: 0.43%
breast life cancer pharmaceuticals results
Sermonix Pharmaceuticals Announces Publication of ELAINE-1 and ELAINE-2 Trial Results in Annals of Oncology
Published: 2023-12-11 (Crawled : 20:00) - biospace.com/
LLY | News | $733.3 -1.66% 1.4M
|
Health Technology
|
| O: 1.61%
H: 0.0%
C: 0.0%
LGND | $70.74 1.22% 63K
|
Health Technology
|
| O: 0.29%
H: 1.26%
C: 0.87%
publication pharmaceuticals trial results
Innovent Announces the Phase 3 ORIENT-16 Study Results Published in JAMA Evaluating Sintilimab in Combination with Chemotherapy for the First-Line Treatment of Gastric or Gastroesophageal Junction (G/GEJ) Adenocarcinoma
Published: 2023-12-06 (Crawled : 01:00) - prnewswire.com
SNYNF | News | $94.25 480
|
Health Technology
|
| O: -2.77%
H: 0.49%
C: 0.49%
LLY | News | $733.3 -1.66% 1.4M
|
Health Technology
|
| O: 0.99%
H: 0.0%
C: 0.0%
SNY | News | $46.765 -1.94% 1.2M
|
Health Technology
|
| O: -0.6%
H: 0.0%
C: 0.0%
INCY | $51.45 -0.39% 720K
|
Health Technology
|
| O: -0.2%
H: 1.7%
C: 1.3%
rient-16 treatment results study
Innovent Announces Publication of Mazdutide (IBI362) Phase 2 Full Results in Chinese Patients with Type 2 Diabetes in Diabetes Care
Published: 2023-11-22 (Crawled : 05:00) - prnewswire.com
SNYNF | News | $94.25 480
|
Health Technology
|
| O: -0.74%
H: 0.71%
C: 0.71%
LLY | News | $733.3 -1.66% 1.4M
|
Health Technology
|
| O: -0.44%
H: 0.63%
C: -0.05%
SNY | News | $46.765 -1.94% 1.2M
|
Health Technology
|
| O: -0.34%
H: 0.0%
C: 0.0%
ibi362 publication care chinese diabetes results phase 2
POINT Biopharma Reports Third Quarter 2023 Financial Results and Provides Business Highlights
Published: 2023-11-13 (Crawled : 12:30) - globenewswire.com
PNT | $13.68 2.63% 0.15% 0
|
|
| O: -0.95%
H: 0.0%
C: 0.0%
LLY | News | $733.3 -1.66% 1.4M
|
Health Technology
|
| O: -0.26%
H: 4.11%
C: 3.09%
business biopharma financial results
Avidity Biosciences Reports Third Quarter 2023 Financial Results and Recent Highlights
Published: 2023-11-08 (Crawled : 21:00) - prnewswire.com
LLY | News | $733.3 -1.66% 1.4M
|
Health Technology
|
| O: -0.71%
H: 0.14%
C: -3.81%
RNA | News M | $25.2 0.24% 380K
|
Health Technology
|
| O: 3.51%
H: 9.47%
C: -2.32%
financial results
ProQR Announces Third Quarter 2023 Operating and Financial Results
Published: 2023-11-07 (Crawled : 12:00) - globenewswire.com
LLY | News | $733.3 -1.66% 1.4M
|
Health Technology
|
| O: 4.2%
H: 0.83%
C: 0.49%
PRQR | News | $2.0 -0.99% 33K
|
Health Technology
|
| O: -2.46%
H: 21.85%
C: 13.45%
financial results
Verve Therapeutics Highlights Recent Company Progress and Reports Third Quarter 2023 Financial Results
Published: 2023-11-07 (Crawled : 12:00) - globenewswire.com
VERV | $6.62 -3.78% 490K
|
Professional, Scientific, and T...
|
| O: 6.88%
H: 25.67%
C: 16.8%
LLY | News | $733.3 -1.66% 1.4M
|
Health Technology
|
| O: 4.2%
H: 0.83%
C: 0.49%
company therapeutics financial results
Gainers vs Losers
| 58% | 42% |
Top 10 Gainers
CSSE 4 | $0.3831 151.54% 190M
|
Consumer Services
CZOO | $11.04 121.24% 11M
|
LICN | $0.9107 62.63% 14M
|
BOF | $1.87 59.83% 100M
|
AMST | $3.18 59.0% 67M
|
Technology Services
SKIL 4 | $8.72 52.72% 410K
|
Information
MTC | $3.31 47.77% 7.7M
|
Technology Services
MULN | News | $3.915 43.41% 12M
|
Information
WIMI | $1.04 43.37% 17M
|
Technology Services
RILY | $29.755 36.99% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.